ReleaseWire Connect

Urinary incontinence devices market is projected to gather a significant CAGR of 11.3% during the forecast period, 2017-2023. This report is a compilation of the current trends, growth drivers, restraints, market estimates and forecasts, market segmentation, and profiles of the top industry players of the market. It also discusses the market size and share of this market. It enables the interested business owners and individuals understand the entire market with the help of critical industry insights.

The global Artificial intelligence (AI) in healthcare market was valued at $1,441 million in 2016, and is estimated to reach at $22,790 million by 2023, registering a CAGR of 48.7% from 2017 to 2023.

The North American biosurgery market offers lucrative growth opportunities owing to its developed economy, high public awareness, rising patient pool, and arrival of new multifunctional products. Developing countries such as India, China, Brazil, and South Korea are expected to boost the market growth with rapid change in healthcare infrastructure and increase in purchasing power. Increase in medical tourism, heavy investment by top players in R&D activities, and low cost surgeries are projected to boost the market growth during the analysis period, particularly in the Asia-Pacific region.

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.

The U.S. IVD Market was valued at $15,746 million in 2016, and is projected to reach at $20,707 million by 2023, growing at a CAGR of 3.9% from 2017 to 2023. The reagent segment accounted for more than three-fifths share of the total market in 2016.

The global diabetes care devices market was valued at $6,867 million in 2016, and is expected to reach $10,208 million by 2023, growing at a CAGR of 5.8% from 2017 to 2023.

Aquaculture Market Report, published by Allied Market Research, forecasts that the market was valued $169 billion in 2015, and is expected to reach $242 billion by 2022, supported by a CAGR of 5.3% during the forecast period 2016 - 2022.Carps segment is expected to retain its dominant position, in terms of revenue generation, throughout the forecast period. Asia-Pacific held the leading position in the global market in 2015, and is expected to maintain its lead ahead as well.

The Food Flavors Market by Type and End Users: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global food flavors market was valued at $13,172 million in 2017, and is expected to reach at $20,106 million by 2025, registering a CAGR of 5.4% from 2018 to 2025. Flavors are used in various products such as bakery, confectionery, meat, snacks, seafood, and poultry.

Allied Market Research (AMR) has published a new report on Functional Coil Coatings Market, the global market size was valued at $368.5 million in 2017 and is likely to reach at $509 million by 2024 at a CAGR of 4.8%. The use of recyclable coating tools is expected to reduce the expenses on procurement and installation of new tools. Thus, this may lead to higher adoption of functional coil coating process, which is anticipated to provide lucrative opportunity for the functional coil coatings market growth.

According to a new report published by Allied Market Research, titled,"Bioinformatics Market by Technology & Services, Application, and Sector: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global bioinformatics market size is $6,389 million in 2017, and is projected to reach $18,233 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The bioinformatics platforms segment accounted for nearly half of the total bioinformatics market share in 2017.